Some studies have reported that ASF1B may induce differentiation of sarcomatoid phenotype as a prognostic indicator by regulating the microenvironment and epithelial-mesenchymal transition in malignant mesothelioma (18). This evidence concerns the gene ASF1B and malignant mesothelioma.